_id
69147bd2ccc777a4e85d90ad
Ticker
MRNA
Name
Moderna Inc
Exchange
NASDAQ
Address
325 Binney Street, Cambridge, MA, United States, 02142
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.modernatx.com
Description
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Last Close
29.92
Volume
9568281
Current Price
29.6799
Change
-0.8024732620320915
Last Updated
2025-12-02T12:07:02.486Z
Image
-
Ipo Date
2018-12-07T00:00:00.000Z
Market Cap
9440124928
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.5840183333333332
Sentiment Sources
120
Rating
3.2222
Target Price
37.2105
Strong Buy
5
Buy
1
Hold
17
Sell
3
Strong Sell
1
Current Quarter
2025-09-30
Revenue
1016000000
Cost Of Revenue
1008000000
Gross Profit
8000000
Operating Expenses
268000000
Operating Income
-260000000
Interest Expense
0
Pretax Income
-187000000
Net Income
-200000000
Eps
-0.5128205128205128
Dividends Per Share
-
Shares Outstanding
390733636
Income Tax Expense
13000000
EBITDA
-135000000
Operating Margin
-25.590551181102363
Total Other Income Expense Net
73000000
Cash
1132000000
Short Term Investments
3372000000
Receivables
1394000000
Inventories
332000000
Total Current Assets
6598000000
Property Plant Equipment
2864000000
Total Assets
12135000000
Payables
267000000
Short Term Debt
48000000
Long Term Debt
-
Total Liabilities
2805000000
Equity
9330000000
Depreciation
52000000
Change In Working Capital
-818000000
Cash From Operations
-847000000
Capital Expenditures
33000000
Cash From Investing
700000000
Cash From Financing
-1000000
Net Change In Cash
-148000000
PE
-
PB
1.2406389067524115
ROE
-2.1436227224008575
ROA
-1.6481252575195715
FCF
-880000000
Fcf Percent
-0.8661417322834646
Piotroski FScore
0
Health Score
34
Deep Value Investing Score
5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
4.5
Growth Investing Score
3
Momentum Investing Score
4
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1016000000
Quarters > 0 > income Statement > cost Of Revenue
1008000000
Quarters > 0 > income Statement > gross Profit
8000000
Quarters > 0 > income Statement > operating Expenses
268000000
Quarters > 0 > income Statement > operating Income
-260000000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-187000000
Quarters > 0 > income Statement > net Income
-200000000
Quarters > 0 > income Statement > eps
-0.5128205128205128
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
390000000
Quarters > 0 > income Statement > income Tax Expense
13000000
Quarters > 0 > income Statement > EBITDA
-135000000
Quarters > 0 > income Statement > operating Margin
-25.590551181102363
Quarters > 0 > income Statement > total Other Income Expense Net
73000000
Quarters > 0 > balance Sheet > cash
1132000000
Quarters > 0 > balance Sheet > short Term Investments
3372000000
Quarters > 0 > balance Sheet > receivables
1394000000
Quarters > 0 > balance Sheet > inventories
332000000
Quarters > 0 > balance Sheet > total Current Assets
6598000000
Quarters > 0 > balance Sheet > property Plant Equipment
2864000000
Quarters > 0 > balance Sheet > total Assets
12135000000
Quarters > 0 > balance Sheet > payables
267000000
Quarters > 0 > balance Sheet > short Term Debt
48000000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2805000000
Quarters > 0 > balance Sheet > equity
9330000000
Quarters > 0 > cash Flow > net Income
-200000000
Quarters > 0 > cash Flow > depreciation
52000000
Quarters > 0 > cash Flow > change In Working Capital
-818000000
Quarters > 0 > cash Flow > cash From Operations
-847000000
Quarters > 0 > cash Flow > capital Expenditures
33000000
Quarters > 0 > cash Flow > cash From Investing
700000000
Quarters > 0 > cash Flow > cash From Financing
-1000000
Quarters > 0 > cash Flow > net Change In Cash
-148000000
Quarters > 0 > ratios > PE
-0.5128205128205128
Quarters > 0 > ratios > PB
1.2406389067524115
Quarters > 0 > ratios > ROE
-2.1436227224008575
Quarters > 0 > ratios > ROA
-1.6481252575195715
Quarters > 0 > ratios > FCF
-880000000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-0.8661417322834646
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
142000000
Quarters > 1 > income Statement > cost Of Revenue
119000000
Quarters > 1 > income Statement > gross Profit
23000000
Quarters > 1 > income Statement > operating Expenses
930000000
Quarters > 1 > income Statement > operating Income
-907000000
Quarters > 1 > income Statement > interest Expense
1000000
Quarters > 1 > income Statement > pretax Income
-818000000
Quarters > 1 > income Statement > net Income
-825000000
Quarters > 1 > income Statement > eps
-2.1262886597938144
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
388000000
Quarters > 1 > income Statement > income Tax Expense
7000000
Quarters > 1 > income Statement > EBITDA
-760000000
Quarters > 1 > income Statement > operating Margin
-638.7323943661972
Quarters > 1 > income Statement > total Other Income Expense Net
89000000
Quarters > 1 > balance Sheet > cash
1279000000
Quarters > 1 > balance Sheet > short Term Investments
3852000000
Quarters > 1 > balance Sheet > receivables
457000000
Quarters > 1 > balance Sheet > inventories
240000000
Quarters > 1 > balance Sheet > total Current Assets
6171000000
Quarters > 1 > balance Sheet > property Plant Equipment
2919000000
Quarters > 1 > balance Sheet > total Assets
12010000000
Quarters > 1 > balance Sheet > payables
175000000
Quarters > 1 > balance Sheet > short Term Debt
43000000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2611000000
Quarters > 1 > balance Sheet > equity
9399000000
Quarters > 1 > cash Flow > net Income
-825000000
Quarters > 1 > cash Flow > depreciation
57000000
Quarters > 1 > cash Flow > change In Working Capital
-297000000
Quarters > 1 > cash Flow > cash From Operations
-919000000
Quarters > 1 > cash Flow > capital Expenditures
3000000
Quarters > 1 > cash Flow > cash From Investing
564000000
Quarters > 1 > cash Flow > cash From Financing
9000000
Quarters > 1 > cash Flow > net Change In Cash
-345000000
Quarters > 1 > ratios > PE
-2.1262886597938144
Quarters > 1 > ratios > PB
1.2252155761251198
Quarters > 1 > ratios > ROE
-8.77752952441749
Quarters > 1 > ratios > ROA
-6.869275603663613
Quarters > 1 > ratios > FCF
-922000000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-6.492957746478873
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
107000000
Quarters > 2 > income Statement > cost Of Revenue
90000000
Quarters > 2 > income Statement > gross Profit
17000000
Quarters > 2 > income Statement > operating Expenses
1067000000
Quarters > 2 > income Statement > operating Income
-1050000000
Quarters > 2 > income Statement > interest Expense
1000000
Quarters > 2 > income Statement > pretax Income
-964000000
Quarters > 2 > income Statement > net Income
-971000000
Quarters > 2 > income Statement > eps
-2.5155440414507773
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
386000000
Quarters > 2 > income Statement > income Tax Expense
7000000
Quarters > 2 > income Statement > EBITDA
-924000000
Quarters > 2 > income Statement > operating Margin
-981.3084112149533
Quarters > 2 > income Statement > total Other Income Expense Net
86000000
Quarters > 2 > balance Sheet > cash
1623000000
Quarters > 2 > balance Sheet > short Term Investments
4352000000
Quarters > 2 > balance Sheet > receivables
306000000
Quarters > 2 > balance Sheet > inventories
128000000
Quarters > 2 > balance Sheet > total Current Assets
6766000000
Quarters > 2 > balance Sheet > property Plant Equipment
2964000000
Quarters > 2 > balance Sheet > total Assets
12704000000
Quarters > 2 > balance Sheet > payables
226000000
Quarters > 2 > balance Sheet > short Term Debt
43000000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2638000000
Quarters > 2 > balance Sheet > equity
10066000000
Quarters > 2 > cash Flow > net Income
-971000000
Quarters > 2 > cash Flow > depreciation
39000000
Quarters > 2 > cash Flow > change In Working Capital
-211000000
Quarters > 2 > cash Flow > cash From Operations
-1037000000
Quarters > 2 > cash Flow > capital Expenditures
127000000
Quarters > 2 > cash Flow > cash From Investing
730000000
Quarters > 2 > cash Flow > cash From Financing
4000000
Quarters > 2 > cash Flow > net Change In Cash
-303000000
Quarters > 2 > ratios > PE
-2.5155440414507773
Quarters > 2 > ratios > PB
1.138132465726207
Quarters > 2 > ratios > ROE
-9.646334194317504
Quarters > 2 > ratios > ROA
-7.643261964735516
Quarters > 2 > ratios > FCF
-1164000000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-10.878504672897197
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
956000000
Quarters > 3 > income Statement > cost Of Revenue
739000000
Quarters > 3 > income Statement > gross Profit
217000000
Quarters > 3 > income Statement > operating Expenses
1463000000
Quarters > 3 > income Statement > operating Income
-1246000000
Quarters > 3 > income Statement > interest Expense
6000000
Quarters > 3 > income Statement > pretax Income
-1184000000
Quarters > 3 > income Statement > net Income
-1120000000
Quarters > 3 > income Statement > eps
-2.909090909090909
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
385000000
Quarters > 3 > income Statement > income Tax Expense
-64000000
Quarters > 3 > income Statement > EBITDA
-1118000000
Quarters > 3 > income Statement > operating Margin
-130.3347280334728
Quarters > 3 > income Statement > total Other Income Expense Net
62000000
Quarters > 3 > balance Sheet > cash
1927000000
Quarters > 3 > balance Sheet > short Term Investments
5098000000
Quarters > 3 > balance Sheet > receivables
592000000
Quarters > 3 > balance Sheet > inventories
117000000
Quarters > 3 > balance Sheet > total Current Assets
8099000000
Quarters > 3 > balance Sheet > property Plant Equipment
2955000000
Quarters > 3 > balance Sheet > total Assets
14142000000
Quarters > 3 > balance Sheet > payables
405000000
Quarters > 3 > balance Sheet > short Term Debt
37000000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3241000000
Quarters > 3 > balance Sheet > equity
10901000000
Quarters > 3 > cash Flow > net Income
-1120000000
Quarters > 3 > cash Flow > depreciation
60000000
Quarters > 3 > cash Flow > change In Working Capital
1737000000
Quarters > 3 > cash Flow > cash From Operations
825000000
Quarters > 3 > cash Flow > capital Expenditures
522000000
Quarters > 3 > cash Flow > cash From Investing
-539000000
Quarters > 3 > cash Flow > cash From Financing
-3000000
Quarters > 3 > cash Flow > net Change In Cash
282000000
Quarters > 3 > ratios > PE
-2.909090909090909
Quarters > 3 > ratios > PB
1.0482305751765892
Quarters > 3 > ratios > ROE
-10.274286762682323
Quarters > 3 > ratios > ROA
-7.919671899307029
Quarters > 3 > ratios > FCF
303000000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.3169456066945607
Quarters > 3 > health Score
54
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
3199000000
Annuals > 0 > income Statement > cost Of Revenue
1464000000
Annuals > 0 > income Statement > gross Profit
1735000000
Annuals > 0 > income Statement > operating Expenses
5680000000
Annuals > 0 > income Statement > operating Income
-3945000000
Annuals > 0 > income Statement > interest Expense
24000000
Annuals > 0 > income Statement > pretax Income
-3607000000
Annuals > 0 > income Statement > net Income
-3561000000
Annuals > 0 > income Statement > eps
-9.2734375
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
384000000
Annuals > 0 > income Statement > income Tax Expense
-46000000
Annuals > 0 > income Statement > EBITDA
-3394000000
Annuals > 0 > income Statement > operating Margin
-123.319787433573
Annuals > 0 > income Statement > total Other Income Expense Net
338000000
Annuals > 0 > balance Sheet > cash
1927000000
Annuals > 0 > balance Sheet > short Term Investments
5098000000
Annuals > 0 > balance Sheet > receivables
592000000
Annuals > 0 > balance Sheet > inventories
117000000
Annuals > 0 > balance Sheet > total Current Assets
8099000000
Annuals > 0 > balance Sheet > property Plant Equipment
2955000000
Annuals > 0 > balance Sheet > total Assets
14142000000
Annuals > 0 > balance Sheet > payables
405000000
Annuals > 0 > balance Sheet > short Term Debt
37000000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3241000000
Annuals > 0 > balance Sheet > equity
10901000000
Annuals > 0 > cash Flow > net Income
-3561000000
Annuals > 0 > cash Flow > depreciation
189000000
Annuals > 0 > cash Flow > change In Working Capital
-78000000
Annuals > 0 > cash Flow > cash From Operations
-3004000000
Annuals > 0 > cash Flow > capital Expenditures
1051000000
Annuals > 0 > cash Flow > cash From Investing
1949000000
Annuals > 0 > cash Flow > cash From Financing
56000000
Annuals > 0 > cash Flow > net Change In Cash
-999000000
Annuals > 0 > ratios > PE
-9.2734375
Annuals > 0 > ratios > PB
0.8510632052105311
Annuals > 0 > ratios > ROE
-32.666727823135496
Annuals > 0 > ratios > ROA
-25.180313958421724
Annuals > 0 > ratios > FCF
-4055000000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.267583619881213
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
6848000000
Annuals > 1 > income Statement > cost Of Revenue
4693000000
Annuals > 1 > income Statement > gross Profit
2155000000
Annuals > 1 > income Statement > operating Expenses
6394000000
Annuals > 1 > income Statement > operating Income
-4239000000
Annuals > 1 > income Statement > interest Expense
38000000
Annuals > 1 > income Statement > pretax Income
-3942000000
Annuals > 1 > income Statement > net Income
-4714000000
Annuals > 1 > income Statement > eps
-12.340314136125654
Annuals > 1 > income Statement > dividends Per Share
270000000
Annuals > 1 > income Statement > shares Outstanding
382000000
Annuals > 1 > income Statement > income Tax Expense
772000000
Annuals > 1 > income Statement > EBITDA
-3283000000
Annuals > 1 > income Statement > operating Margin
-61.90128504672897
Annuals > 1 > income Statement > total Other Income Expense Net
297000000
Annuals > 1 > balance Sheet > cash
2907000000
Annuals > 1 > balance Sheet > short Term Investments
5697000000
Annuals > 1 > balance Sheet > receivables
1081000000
Annuals > 1 > balance Sheet > inventories
202000000
Annuals > 1 > balance Sheet > total Current Assets
10325000000
Annuals > 1 > balance Sheet > property Plant Equipment
2658000000
Annuals > 1 > balance Sheet > total Assets
18426000000
Annuals > 1 > balance Sheet > payables
520000000
Annuals > 1 > balance Sheet > short Term Debt
25000000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4572000000
Annuals > 1 > balance Sheet > equity
13854000000
Annuals > 1 > cash Flow > net Income
-4714000000
Annuals > 1 > cash Flow > depreciation
621000000
Annuals > 1 > cash Flow > change In Working Capital
-139000000
Annuals > 1 > cash Flow > cash From Operations
-3118000000
Annuals > 1 > cash Flow > capital Expenditures
707000000
Annuals > 1 > cash Flow > cash From Investing
4206000000
Annuals > 1 > cash Flow > cash From Financing
-1377000000
Annuals > 1 > cash Flow > net Change In Cash
-289000000
Annuals > 1 > ratios > PE
-12.340314136125654
Annuals > 1 > ratios > PB
0.666170059188682
Annuals > 1 > ratios > ROE
-34.02627400028872
Annuals > 1 > ratios > ROA
-25.583414740041242
Annuals > 1 > ratios > FCF
-3825000000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.5585572429906542
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
18875000000
Annuals > 2 > income Statement > cost Of Revenue
5416000000
Annuals > 2 > income Statement > gross Profit
13459000000
Annuals > 2 > income Statement > operating Expenses
4039000000
Annuals > 2 > income Statement > operating Income
9420000000
Annuals > 2 > income Statement > interest Expense
29000000
Annuals > 2 > income Statement > pretax Income
9575000000
Annuals > 2 > income Statement > net Income
8362000000
Annuals > 2 > income Statement > eps
20.10096153846154
Annuals > 2 > income Statement > dividends Per Share
184000000
Annuals > 2 > income Statement > shares Outstanding
416000000
Annuals > 2 > income Statement > income Tax Expense
1213000000
Annuals > 2 > income Statement > EBITDA
9768000000
Annuals > 2 > income Statement > operating Margin
49.907284768211916
Annuals > 2 > income Statement > total Other Income Expense Net
155000000
Annuals > 2 > balance Sheet > cash
3205000000
Annuals > 2 > balance Sheet > short Term Investments
6697000000
Annuals > 2 > balance Sheet > receivables
1685000000
Annuals > 2 > balance Sheet > inventories
949000000
Annuals > 2 > balance Sheet > total Current Assets
13431000000
Annuals > 2 > balance Sheet > property Plant Equipment
2139000000
Annuals > 2 > balance Sheet > total Assets
25858000000
Annuals > 2 > balance Sheet > payables
487000000
Annuals > 2 > balance Sheet > short Term Debt
196000000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
6735000000
Annuals > 2 > balance Sheet > equity
19123000000
Annuals > 2 > cash Flow > net Income
8362000000
Annuals > 2 > cash Flow > depreciation
348000000
Annuals > 2 > cash Flow > change In Working Capital
-3455000000
Annuals > 2 > cash Flow > cash From Operations
4981000000
Annuals > 2 > cash Flow > capital Expenditures
400000000
Annuals > 2 > cash Flow > cash From Investing
-5176000000
Annuals > 2 > cash Flow > cash From Financing
-3448000000
Annuals > 2 > cash Flow > net Change In Cash
-3643000000
Annuals > 2 > ratios > PE
20.10096153846154
Annuals > 2 > ratios > PB
0.525574439157036
Annuals > 2 > ratios > ROE
43.72744862207812
Annuals > 2 > ratios > ROA
32.33815453631371
Annuals > 2 > ratios > FCF
4581000000
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.24270198675496688
Annuals > 2 > health Score
89
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
17736000000
Annuals > 3 > income Statement > cost Of Revenue
2617000000
Annuals > 3 > income Statement > gross Profit
15119000000
Annuals > 3 > income Statement > operating Expenses
1823000000
Annuals > 3 > income Statement > operating Income
13296000000
Annuals > 3 > income Statement > interest Expense
18000000
Annuals > 3 > income Statement > pretax Income
13285000000
Annuals > 3 > income Statement > net Income
12202000000
Annuals > 3 > income Statement > eps
28.31090487238979
Annuals > 3 > income Statement > dividends Per Share
124000000
Annuals > 3 > income Statement > shares Outstanding
431000000
Annuals > 3 > income Statement > income Tax Expense
1083000000
Annuals > 3 > income Statement > EBITDA
13528000000
Annuals > 3 > income Statement > operating Margin
74.96617050067658
Annuals > 3 > income Statement > total Other Income Expense Net
-11000000
Annuals > 3 > balance Sheet > cash
6848000000
Annuals > 3 > balance Sheet > short Term Investments
3879000000
Annuals > 3 > balance Sheet > receivables
3323000000
Annuals > 3 > balance Sheet > inventories
1441000000
Annuals > 3 > balance Sheet > total Current Assets
16071000000
Annuals > 3 > balance Sheet > property Plant Equipment
1383000000
Annuals > 3 > balance Sheet > total Assets
24669000000
Annuals > 3 > balance Sheet > payables
302000000
Annuals > 3 > balance Sheet > short Term Debt
211000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10524000000
Annuals > 3 > balance Sheet > equity
14145000000
Annuals > 3 > cash Flow > net Income
12202000000
Annuals > 3 > cash Flow > depreciation
232000000
Annuals > 3 > cash Flow > change In Working Capital
990000000
Annuals > 3 > cash Flow > cash From Operations
13620000000
Annuals > 3 > cash Flow > capital Expenditures
284000000
Annuals > 3 > cash Flow > cash From Investing
-8523000000
Annuals > 3 > cash Flow > cash From Financing
-873000000
Annuals > 3 > cash Flow > net Change In Cash
4224000000
Annuals > 3 > ratios > PE
28.31090487238979
Annuals > 3 > ratios > PB
0.736158359844468
Annuals > 3 > ratios > ROE
86.2636974195829
Annuals > 3 > ratios > ROA
49.46288864566865
Annuals > 3 > ratios > FCF
13336000000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.7519170049616599
Annuals > 3 > health Score
82
Valuation > metrics > PE
-0.5128205128205128
Valuation > metrics > PB
1.2406389067524115
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-2.1436227224008575
Profitability > metrics > ROA
-3.031221582297666
Profitability > metrics > Net Margin
-0.1968503937007874
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.30064308681672025
Risk > metrics > Interest Coverage
-5
Risk > final Score
40
Risk > verdict
High
Liquidity > metrics > Current Ratio
20.946031746031746
Liquidity > metrics > Quick Ratio
19.892063492063492
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-3568
Prev Risks > 1
-4140
Prev Risks > 2
-771
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T23:01:44.050Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-10-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.51
Earnings History > 0 > eps Estimate
-2.05
Earnings History > 0 > eps Difference
1.54
Earnings History > 0 > surprise Percent
75.122
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-01
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-2.13
Earnings History > 1 > eps Estimate
-2.98
Earnings History > 1 > eps Difference
0.85
Earnings History > 1 > surprise Percent
28.5235
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-30
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-2.52
Earnings History > 2 > eps Estimate
-3.03
Earnings History > 2 > eps Difference
0.51
Earnings History > 2 > surprise Percent
16.8317
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-02-20
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-2.91
Earnings History > 3 > eps Estimate
-2.7599
Earnings History > 3 > eps Difference
-0.1501
Earnings History > 3 > surprise Percent
-5.4386
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.03
Earnings History > 4 > eps Estimate
-1.9
Earnings History > 4 > eps Difference
1.93
Earnings History > 4 > surprise Percent
101.5789
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-01
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-3.33
Earnings History > 5 > eps Estimate
-3.38
Earnings History > 5 > eps Difference
0.05
Earnings History > 5 > surprise Percent
1.4793
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-02
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-3.07
Earnings History > 6 > eps Estimate
-3.58
Earnings History > 6 > eps Difference
0.51
Earnings History > 6 > surprise Percent
14.2458
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-02-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.55
Earnings History > 7 > eps Estimate
-0.97
Earnings History > 7 > eps Difference
1.52
Earnings History > 7 > surprise Percent
156.701
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-02
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-9.53
Earnings History > 8 > eps Estimate
-1.93
Earnings History > 8 > eps Difference
-7.6
Earnings History > 8 > surprise Percent
-393.7824
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-03
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-3.62
Earnings History > 9 > eps Estimate
-4.04
Earnings History > 9 > eps Difference
0.42
Earnings History > 9 > surprise Percent
10.396
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-04
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.19
Earnings History > 10 > eps Estimate
-1.77
Earnings History > 10 > eps Difference
1.96
Earnings History > 10 > surprise Percent
110.7345
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-02-23
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
3.61
Earnings History > 11 > eps Estimate
4.68
Earnings History > 11 > eps Difference
-1.07
Earnings History > 11 > surprise Percent
-22.8632
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-03
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
2.53
Earnings History > 12 > eps Estimate
3.29
Earnings History > 12 > eps Difference
-0.76
Earnings History > 12 > surprise Percent
-23.1003
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-03
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
5.24
Earnings History > 13 > eps Estimate
4.55
Earnings History > 13 > eps Difference
0.69
Earnings History > 13 > surprise Percent
15.1648
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-04
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
8.58
Earnings History > 14 > eps Estimate
5.21
Earnings History > 14 > eps Difference
3.37
Earnings History > 14 > surprise Percent
64.6833
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-02-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
11.29
Earnings History > 15 > eps Estimate
9.9
Earnings History > 15 > eps Difference
1.39
Earnings History > 15 > surprise Percent
14.0404
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-04
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
7.7
Earnings History > 16 > eps Estimate
9.05
Earnings History > 16 > eps Difference
-1.35
Earnings History > 16 > surprise Percent
-14.9171
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-05
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
6.46
Earnings History > 17 > eps Estimate
5.96
Earnings History > 17 > eps Difference
0.5
Earnings History > 17 > surprise Percent
8.3893
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-06
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
2.84
Earnings History > 18 > eps Estimate
2.39
Earnings History > 18 > eps Difference
0.45
Earnings History > 18 > surprise Percent
18.8285
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-02-25
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.69
Earnings History > 19 > eps Estimate
-0.35
Earnings History > 19 > eps Difference
-0.34
Earnings History > 19 > surprise Percent
-97.1429
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-10-29
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.59
Earnings History > 20 > eps Estimate
-0.43
Earnings History > 20 > eps Difference
-0.16
Earnings History > 20 > surprise Percent
-37.2093
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-05
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.31
Earnings History > 21 > eps Estimate
-0.35
Earnings History > 21 > eps Difference
0.04
Earnings History > 21 > surprise Percent
11.4286
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
BeforeMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.35
Earnings History > 22 > eps Estimate
-0.35
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
0
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-02-26
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.37
Earnings History > 23 > eps Estimate
-0.42
Earnings History > 23 > eps Difference
0.05
Earnings History > 23 > surprise Percent
11.9048
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-06
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.37
Earnings History > 24 > eps Estimate
-0.43
Earnings History > 24 > eps Difference
0.06
Earnings History > 24 > surprise Percent
13.9535
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-07
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
BeforeMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.41
Earnings History > 25 > eps Estimate
-0.44
Earnings History > 25 > eps Difference
0.03
Earnings History > 25 > surprise Percent
6.8182
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-08
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
BeforeMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.4
Earnings History > 26 > eps Estimate
-0.36
Earnings History > 26 > eps Difference
-0.04
Earnings History > 26 > surprise Percent
-11.1111
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-06
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
BeforeMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-1.78
Earnings History > 27 > eps Estimate
-0.36
Earnings History > 27 > eps Difference
-1.42
Earnings History > 27 > surprise Percent
-394.4444
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-12-07
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.52
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
-0.52
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-06-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.29
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ANew mRNA flu shot moves to major trial in push to blunt the next pandemic Stock Titan
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$37.2105
Analyst Picks
Strong Buy
5
Buy
1
Hold
17
Sell
3
Strong Sell
1
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 79.61% of the total shares of Moderna Inc
1.
Vanguard Group Inc(10.7198%)
since
2025/06/30
2.
BlackRock Inc(7.3536%)
since
2025/06/30
3.
Baillie Gifford & Co Limited.(5.6786%)
since
2025/06/30
4.
FMR Inc(5.0492%)
since
2025/06/30
5.
State Street Corp(4.4388%)
since
2025/06/30
6.
Vanguard Total Stock Mkt Idx Inv(2.8181%)
since
2025/07/31
7.
Geode Capital Management, LLC(2.2816%)
since
2025/06/30
8.
Scottish Mortgage Ord(2.2183%)
since
2025/06/30
9.
Vanguard Small Cap Index(2.172%)
since
2025/07/31
10.
Vanguard 500 Index Investor(2.1659%)
since
2025/07/31
11.
Morgan Stanley - Brokerage Accounts(2.0827%)
since
2025/06/30
12.
Theleme Partners LLP(2.0224%)
since
2025/06/30
13.
Two Sigma Advisers, LLC(2.0088%)
since
2025/06/30
14.
D. E. Shaw & Co LP(1.9183%)
since
2025/06/30
15.
Amvescap Plc.(1.8251%)
since
2025/06/30
16.
Two Sigma Investments LLC(1.7886%)
since
2025/06/30
17.
Fidelity Growth Compy Commingled Pl S(1.749%)
since
2025/07/31
18.
Vanguard International Growth Inv(1.6451%)
since
2025/06/30
19.
Vanguard Small Cap Value Index Inv(1.3973%)
since
2025/07/31
20.
Invesco S&P 500® Equal Weight ETF(1.3104%)
since
2025/08/29
21.
Fidelity Growth Company Fund(1.2952%)
since
2025/07/31
22.
Flagship Ventures Management, Inc.(1.1905%)
since
2025/06/30
23.
Fidelity 500 Index(1.1088%)
since
2025/07/31
24.
SPDR® S&P Biotech ETF(1.0865%)
since
2025/08/31
25.
SPDR® S&P 500® ETF(1.0538%)
since
2025/08/31
26.
iShares Core S&P 500 ETF(1.0526%)
since
2025/08/31
27.
UBS Group AG(1.0132%)
since
2025/06/30
28.
Jane Street Group LLC(0.972%)
since
2025/06/30
29.
NORGES BANK(0.8841%)
since
2025/06/30
30.
VOLORIDGE INVESTMENT MANAGEMENT, LLC(0.8747%)
since
2025/06/30
31.
Goldman Sachs Group Inc(0.8747%)
since
2025/06/30
32.
Banque Pictet & Cie SA(0.8052%)
since
2025/06/30
33.
Northern Trust Corp(0.7943%)
since
2025/06/30
34.
Baillie Gifford US Equity Growth(0.7343%)
since
2024/12/31
35.
Vanguard US Growth Investor(0.6924%)
since
2025/06/30
36.
The Health Care Select Sector SPDR® ETF(0.5973%)
since
2025/08/31
37.
Vanguard Institutional Index I(0.5297%)
since
2025/07/31
38.
iShares Biotechnology ETF(0.525%)
since
2025/08/31
39.
State St S&P 500® Indx SL Cl III(0.467%)
since
2025/08/31
40.
BB Biotech AG Ord(0.4112%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.51
EPS Estimate
-2.05
EPS Difference
1.54
Surprise Percent
75.122%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.